Selecting an RBQM software provider has become a critical decision for sponsors and CROs operating under ICH E6(R3). Risk-based quality management is no longer viewed as a monitoring tactic, but rather as an operating model that must support defensible decisions throughout the trial and portfolio lifecycle.
Selecting an RBQM software provider has become a critical decision for sponsors and CROs operating under ICH E6(R3). Risk-based quality management is no longer viewed as a monitoring tactic, but as an operating model that must connect protocol risk, monitoring signals, human decisions, documented actions, and oversight evidence throughout the trial and portfolio lifecycle.
Reduced on-site monitoring effort through risk-based prioritization
Faster path to database lock via earlier issue detection
Avoidable cost exposure reduced per study through proactive oversight
Current guidance under ICH E6(R3), E8(R1), and Q9(R1) does not mandate specific tools. However, it does expect sponsors to demonstrate:
Early identification of Critical to Quality (CtQ) factors
Continuous, data-driven risk evaluation
Clear prioritization and escalation logic
Documented rationale for oversight decisions
Consistent application across studies and portfolios
An RBQM software provider must therefore support traceability across the full oversight chain, not just dashboards.
While many vendors offer RBQM-labeled functionality, meaningful differences emerge in execution.
1. RBQM as an operating model, not a feature set
Leading RBQM technology vendors embed risk thinking from protocol design through study close-out. This includes protocol complexity assessment, risk libraries, and structured CtQ mapping, not only centralized monitoring outputs.
2. Portfolio-level visibility
RBQM platforms that operate study by study often miss systemic risk.
Portfolio-grade RBQM software enables sponsors to detect recurring design issues, vendor patterns, and regional risk signals earlier.
3. Decision support, not automation
Modern RBQM software increasingly uses AI-supported analytics. The differentiator is not automation, but whether technology reduces friction between data, insight, and accountable human judgment.
4. Inspection readiness by design
RBQM technology vendors must support contemporaneous documentation of decisions, not retrospective reconstruction during audits.
5. Connected Evidence Architecture
Mature RBQM technology should connect the operational layers around risk. Protocol complexity, risk assessment, KRIs, QTLs, centralized monitoring, subject-level evidence, medical review, issue management, and documented actions should not be siloed in separate workflows. They should establish a traceable evidence chain showing how identified risks affected study conduct.
Cyntegrity is a pure-play RBQM software provider focused exclusively on risk-based quality management for clinical trials.
Rather than positioning RBQM as a monitoring optimization layer, Cyntegrity supports RBQM as a decision-centric operating model aligned with regulatory intent.
This is where Connected Evidence Architecture becomes practical. The MyRBQM® Portal is designed to connect risk identification with the operational signals, patient-level evidence, human review, and documented actions that demonstrate how oversight decisions were made and why they were appropriate.
Core Capabilities
The MyRBQM® Portal supports:
AI-supported analytics are used to surface signals earlier, while decision accountability remains with study and portfolio owners. The objective is not automated decision-making, but faster, clearer, and better-documented human oversight.
Security, Compliance, and Trust
An RBQM software provider must meet enterprise-grade security and compliance expectations.
Cyntegrity provides:
Microsoft Azure cloud infrastructure
SOC 2 Type II compliance
ISO 9001:2015 certified quality management system
Healthcare AI certification from Microsoft
These foundations support inspection readiness and data protection across global trial portfolios.
Beyond Software: Education and Implementation Support
Technology alone does not establish RBQM maturity.
Cyntegrity complements its platform with:
MyRBQM® Academy, role-based RBQM training and certification
Expert implementation and functional service provision
Change-management support aligned with ICH expectations
This ensures RBQM adoption is operationally sustainable, not tool-dependent.
When assessing RBQM software providers, sponsors, and CROs should ask:
Does the platform support RBQM decisions or just risk reporting?
Can oversight rationale be reconstructed during inspection?
Is RBQM applied consistently across studies and portfolios?
How is protocol complexity addressed upfront?
How are people, process, and technology aligned?
These questions matter more than feature counts.
As regulatory expectations mature, organizations increasingly differentiate between RBQM technology vendors that report risk and those that support oversight decisions.
As regulatory expectations mature, organizations increasingly differentiate between RBQM technology vendors that report risk and those that support oversight decisions.
As inspections increasingly focus on explainability, decision traceability, and evidence of proportionate oversight, the choice of RBQM software provider directly affects risk exposure, rework, and inspection outcomes.
When RBQM is treated as an operating model, uncertainty decreases. When it is treated as a reporting obligation, risk accumulates.
The difference is whether the organization can prove that risk assessment changed study conduct.
Design out avoidable risk before FPFV. AI-augmented protocol analysis surfaces CtQs, quantifies complexity, predicts deviation hot-spots, and reduces amendment drag, so you lock in patient-safe, inspection-ready design from day one.
Operationalize RBQM with verifiable math. AI-guided RACTs, calculation transparency, RBAC-secured workflows, and cross-study analytics deliver proportionate controls, clear KRI/QTL governance, and faster, defensible decisions at scale.
Move beyond manual cleaning and fragmented reviews. With time-series anomaly detection, protocol-aware deviation checks, and structured reasoning, the MyRBQM® Portal highlights what truly requires attention.
Stay ahead of issues, not behind them. Portfolio-wide, AI-enhanced dashboards fuse KRIs, QTLs, and deviation signals to cut escalation latency and focus monitors on high-value actions, fully aligned with ICH expectations.
See the full patient story—fast. Subject Profiles synthesize visits, AEs, ConMeds, labs, and trendlines, accelerating case review and improving safety decisions with transparent traceability and RBAC-controlled access.
Fast, secure connectivity with your clinical platforms through ready-made endpoints and low-overhead, real-time or batch data sync.
Pre-engineered, validated connectors to major EDC systems — reducing integration time while enabling secure, real-time or scheduled data sync.
Seamlessly connect your enterprise data platforms with secure, governed, low-overhead sync — without restructuring your existing data lake.
Our platform and processes meet internationally recognized security, availability, and confidentiality standards. ISO 27001:2022 certification and SOC 2 examinations provide independently verified assurance of our information security controls.
Our clinical-grade AI is independently certified through Microsoft’s Healthcare AI program, ensuring transparent, human-guided oversight, responsible AI practices, and secure integration with Azure’s validated infrastructure.
The MyRBQM Portal is built in alignment with 21 CFR Part 11 and GAMP 5, ensuring data integrity, traceability, and suitability for use in regulated clinical research environments.
If you are evaluating an RBQM software provider, the critical question is rarely whether RBQM delivers value.
The more relevant question is how much of that value can be realistically captured, given your operating model, portfolio structure, and oversight maturity.
Industry Solutions
Featured Insights
Start Your Roll-Out
RBQM Capability Pathway
Quick Answers
